Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f0a78b1ef1467bb030df41e3e5700294 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-35 |
filingDate |
1991-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2ba45a69942c1ed652f27a5999ee467 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ca66c23aa7981c397b13f97783ab953 |
publicationDate |
1993-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-H05105626-A |
titleOfInvention |
Antiviral agent |
abstract |
(57) [Abstract] [Purpose] Development of antiviral agents, especially compounds with excellent anti-AIDS virus activity. An antiviral agent which is a naphthalenedisulfonic acid compound having an alkylamide group represented by the formula (I) and a physiologically usable salt thereof. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006522073-A |
priorityDate |
1991-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |